Dermatology Question of the Week: Medical Mysteries
A 46-year-old male with a past medical history of seizure disorder and recently treated cellulitis presents with a pruritic eruption shown below.

Which of the following is the most likely culprit?
A. Acetaminophen
B. Spironolactone
C. Vancomycin
D. Cephalexin
E. Carbamazepine
Rationale: The clinical photograph above demonstrates annular vesicles/bullae as well as crusting consistent with linear IgA bullous dermatosis. Linear IgA bullous dermatosis can have multiple forms including pediatric, adult, and drug-induced forms. Clinical presentation is variable and includes urticarial plaques/papules, hemorrhagic crusting, and papulovesicles. It can present similarly to dermatitis herpetiformis and in similar locations as well. On direct immunofluorescence, a linear deposition of IgA at the dermal-epidermal junction is seen which can help differentiate the disease from dermatitis herpetiformis (although a small subset of patients with dermatitis herpetiformis can have linear deposition). Several medications have been reported to be associated with linear IgA bullous dermatosis.
Correct answer: C. Vancomycin
Vancomycin is the most commonly reported medication with linear IgA bullous dermatosis (LABD). Other potential medications include trimethoprim-sulfamethoxazole, NSAIDs (particularly diclofenac), lithium, phenytoin, amiodarone, captopril, furosemide, and infliximab. Many of these can be memorized using the mnemonic V SAD CLiP = Vancomycin, Sulfas, Amiodarone, Diclofenac, Captopril, Lithium, and Phenytoin. Discontinuation of the causative agent is imperative. Dapsone can be quite helpful.
Incorrect answers: A, B, D, E
Acetaminophen, Spironolactone, Cephalexin, and Carbamazepine are not commonly associated with linear IgA bullous dermatosis.
Additional reading at Fitzpatrick's Dermatology Chapter 58: Linear Immunoglobulin A Dermatosis and Chronic Bullous Disease of Childhood
Create a Free MyAccess Profile
AccessMedicine Network is the place to keep up on new releases for the Access products, get short form didactic content, read up on practice impacting highlights, and watch video featuring authors of your favorite books in medicine. Create a MyAccess profile and follow our contributors to stay informed via email updates.